Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

scientific article

Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOPSYCH.2006.04.026
P932PMC publication ID1964505
P698PubMed publication ID16950219
P5875ResearchGate publication ID6840176

P50authorHarry PantazopoulosQ80206971
P2093author name stringRoss J Baldessarini
Nicholas Lange
Sabina Berretta
P2860cites workElectrophysiological and cognitive function in young euthymic patients with bipolar affective disorderQ48892807
Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brainQ49019867
Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation.Q50995292
Memory and verbal learning functions in twins with bipolar-I disorder, and the role of information-processing speed.Q51930982
Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality.Q52167923
Differences in Ca2+ buffering properties between excitatory and inhibitory hippocampal neurons from the ratQ58191262
Diminished Suppression of the P50 Auditory Evoked Potential in Bipolar Disorder Subjects With a History of PsychosisQ59795838
Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophreniaQ60054580
Reduced GABA uptake sites in the temporal lobe in schizophreniaQ60054596
Postnatal development of the α1 containing GABAA receptor subunit in rat hippocampusQ60462291
A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophreniaQ61713924
Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophreniaQ62612478
Manic-depressive and pure manic states after brain lesionsQ68197694
A review of MRI findings in schizophreniaQ24657354
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem studyQ28141734
Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexinsQ28189235
The medial temporal lobeQ29615990
Prefrontal cortical-amygdalar metabolism in major depressionQ30579598
Frontotemporal neural systems in bipolar disorderQ30739425
Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphologyQ30760640
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findingsQ33206291
GABAergic interneurons: implications for understanding schizophrenia and bipolar disorderQ33948632
Anatomical organization of the parahippocampal-hippocampal networkQ33981189
Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophreniaQ33981274
Hippocampal-neocortical interaction: a hierarchy of associativityQ34031594
New neurochemical markers for psychosis: a working hypothesis of their operationQ34074201
Two-dimensional versus three-dimensional cell counting: a practical perspectiveQ34133239
'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout miceQ34216909
Diagnostic Criteria for Use in Psychiatric ResearchQ34226390
A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal corticesQ69029008
Prenatal developmental disturbances in the limbic allocortex in schizophrenicsQ69518888
Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidineQ69618072
[Neuropathology of schizophrenias]Q70735291
Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjectsQ71479819
Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brainQ71569685
The human entorhinal cortex: a cytoarchitectonic analysisQ71700880
Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfieldQ72000562
Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspectsQ72201148
Parvalbumin-immunoreactive neurons in the entorhinal cortex of the rat: localization, morphology, connectivity and ultrastructureQ72224756
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorderQ73250666
Input and output stations of the entorhinal cortex: superficial vs. deep layers or lateral vs. medial divisions?Q73489988
Quantification without pontification: choosing a method for counting objects in sectioned tissuesQ73712076
Expression of calbindin-D28k and parvalbumin during development of rat's basolateral amygdaloid complexQ73964600
Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamusQ74453176
Voxel-based morphometry in adolescents with bipolar disorder: first resultsQ80321652
GABAA receptor gamma subunits in the prefrontal cortex of patients with schizophrenia and bipolar disorderQ80347395
Estimation of nuclear population from microtome sectionsQ82126847
Amygdala and hippocampal volumes in adolescents and adults with bipolar disorderQ34282011
Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorderQ34331509
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spinesQ34355797
Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of informationQ34456344
Cell pathology in bipolar disorderQ34692741
Neuronal calcium-binding proteins and schizophrenia.Q34775710
Studies of individuals with schizophrenia never treated with antipsychotic medications: a reviewQ34985042
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanismsQ35187199
Neurobiology of emotion perception II: Implications for major psychiatric disordersQ35208704
Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex.Q35631857
Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal modelsQ35796571
The rhinal cortices: a wall of inhibition between the neocortex and the hippocampusQ35935182
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophreniaQ36070114
Coexistence of parvalbumin and GABA in nonpyramidal neurons of the rat entorhinal cortexQ36809073
Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity.Q37295348
Hippocampal and brain stem activation during word retrieval after repeated and semantic encodingQ38432974
GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophreniaQ38523551
Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression.Q40454288
Methods for determining numbers of cells and synapses: a case for more uniform standards of reviewQ40958739
Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophreniaQ41199819
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.Q41395921
Information-processing abnormalities: trait- and state-dependent componentsQ41474814
The medial temporal lobe in schizophreniaQ41581012
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenicsQ41581740
Altered synaptophysin expression as a marker of synaptic pathology in schizophreniaQ41652023
The entorhinal cortex of the monkey: II. Cortical afferentsQ42116756
Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neuronesQ42499459
Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complexQ42512656
The entorhinal cortex of the monkey: III. Subcortical afferentsQ42524296
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorderQ43593933
Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophreniaQ43601374
The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjectsQ43744085
Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brainQ43870684
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortexQ44045573
Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neuronsQ44059494
Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortexQ44167711
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteinsQ44174112
Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampusQ44355455
Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical studyQ44402652
Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groupsQ44466287
Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorderQ44532052
Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology ConsortiumQ44715726
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuitsQ44926893
Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorderQ45003272
Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.Q45081917
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brainsQ45251046
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.Q46022290
Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorderQ46416538
Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorderQ46546217
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactionsQ47354472
Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brainQ47856910
Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.Q47914893
Molecular evidence for mitochondrial dysfunction in bipolar disorderQ48017201
Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesisQ48115373
Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophreniaQ48122394
Topographic organization of the reciprocal connections between the monkey entorhinal cortex and the perirhinal and parahippocampal cortices.Q48163406
Impaired recruitment of the hippocampus during conscious recollection in schizophreniaQ48242681
Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitationQ48347916
Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorderQ48377734
Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificityQ48426648
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressivesQ48438450
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disordersQ48459917
Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkageQ48465361
Intrinsic projections of the retrohippocampal region in the rat brain. I. The subicular complexQ48478733
Perirhinal and postrhinal cortices of the rat: interconnectivity and connections with the entorhinal cortexQ48517432
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenicsQ48521493
A qualitative and quantitative analysis of the entorhinal cortex in schizophreniaQ48572580
A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophreniaQ48581063
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's diseaseQ48590034
Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortexQ48596760
Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopyQ48614993
Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective PatientsQ48633690
Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem studyQ48669559
Cytoarchitecture of the entorhinal cortex in schizophreniaQ48675741
Some cytoarchitectural abnormalities of the entorhinal cortex in schizophreniaQ48691523
Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brainQ48724803
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenicsQ48729184
Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophreniaQ48764868
Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemiaQ48836277
Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjectsQ48855793
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
entorhinal cortexQ2603645
bipolar disorderQ131755
P304page(s)640-652
P577publication date2006-09-01
P1433published inBiological PsychiatryQ4914961
P1476titleParvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia
P478volume61

Reverse relations

cites work (P2860)
Q34391520Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region
Q37143399Bipolar disorder: from genes to behavior pathways
Q38636760Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei.
Q28251880Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder
Q34828363Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders
Q50784007Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders.
Q37035662Early intervention in bipolar disorder, part I: clinical and imaging findings
Q35603175Extracellular matrix abnormalities in schizophrenia
Q34398564Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia
Q37433211Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system
Q36073289GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Q30503608Hippocampal interneurons are abnormal in schizophrenia
Q35400508Hippocampal interneurons in bipolar disorder
Q36960113Immature dentate gyrus: an endophenotype of neuropsychiatric disorders.
Q37147332Is brain banking of psychiatric cases valuable for neurobiological research?
Q30446669Modeling psychiatric disorders at the cellular and network levels
Q90141029Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
Q41646482Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder.
Q34574517Reduced somatostatin in subgenual anterior cingulate cortex in major depression
Q30375488Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.
Q35894870Size and shape of the caudate nucleus in individuals with bipolar affective disorder
Q34279949Stereological Approaches to Identifying Neuropathology in Psychosis
Q38256971Sugar glues for broken neurons
Q33516071T2 relaxation time abnormalities in bipolar disorder and schizophrenia
Q91049124The neuropathology of bipolar disorder: systematic review and meta-analysis
Q52367971The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia.
Q47659457The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress
Q57610553Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia
Q34167002Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia
Q87927295What can we learn about brain donors? Use of clinical information in human postmortem brain research

Search more.